India's Suven Life Sciences jumps on rights issue
** Suven Life Sciences Ltd's shares SUVP.NS jump as much
as 3.1% to 73 rupees, sharpest intraday gain in over a week
** SUVP set to snap for a second session straight
** The drugmaker on Wednesday approved rights issue of
shares in the ratio of 1:2 urn:newsml:reuters.com:*:nFWN31D0NB
** To issue 72.7 mln shares at 55 rupees each, for almost 40
bln rupees
** 150,000+ shares traded by 0617 GMT vs 30-day moving avg
of 350,000+ shares
** Up to last close, stock had fallen 20.5% YTD
(Reporting by Yagnoseni Das in Bengaluru)
((yagnoseni.das@thomsonreuters.com; suvpMobile: +91
6001289066))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant